Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-25-058758

Chief Finance & Strat Officer gave up 3,658 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stelmakh Edward Chief Finance & Strat Officer 2025-12-23 Shares withheld for taxes −3,658 $12.74 $46,603 123,172 D
Loading xslF345X05/wk-form4_1766526748.xml…